India's pharma, traditional-medicine sectors face slowdown

05/8/2013 | PharmaBiz.com (India)

The global economic downturn coupled with government austerity measures have slowed the growth of the Indian pharmaceutical industry as well as the Ayurvedic sector. New regulations imposed by the EU to combat the influx of counterfeit medicines have also slowed exports. The best prospects for growth in Indian pharmaceuticals include developing generics and biosimilars, strengthening drug-manufacturing capability, restructuring businesses to allow mergers and acquisitions, and keeping a sharp focus on global markets, say Indian drug-company officials.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC